Increased angiotensin-converting enzyme activity in cerebrospinal fluid of treated patients with Parkinson's disease. 1994

C H Konings, and M A Kuiper, and P L Bergmans, and A M Grijpma, and G J van Kamp, and E C Wolters
Department of Clinical Chemistry/Br 1.26, Free University Hospital, Amsterdam, The Netherlands.

UI MeSH Term Description Entries
D007703 Peptidyl-Dipeptidase A A peptidyl-dipeptidase that catalyzes the release of a C-terminal dipeptide, oligopeptide-|-Xaa-Yaa, when Xaa is not Pro, and Yaa is neither Asp nor Glu. Thus, conversion of ANGIOTENSIN I to ANGIOTENSIN II, with increase in vasoconstrictor activity, but no action on angiotensin II. It is also able to inactivate BRADYKININ, a potent vasodilator; and has a glycosidase activity which releases GPI-anchored proteins from the membrane by cleaving the mannose linkage in the GPI moiety. (From https://www.uniprot.org April 15, 2020). ACE1 Angiotensin-Converting Enzyme 1,ACE1 Protein,Angiotensin Converting Enzyme,Angiotensin Converting Enzyme 1,Antigens, CD143,CD143 Antigens,Dipeptidyl Carboxypeptidase I,Kininase II,Peptidase P,Angiotensin I-Converting Enzyme,Carboxycathepsin,Dipeptidyl Peptidase A,Kininase A,ACE1 Angiotensin Converting Enzyme 1,Angiotensin I Converting Enzyme,Carboxypeptidase I, Dipeptidyl,Peptidyl Dipeptidase A
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009474 Neurons The basic cellular units of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM. Nerve Cells,Cell, Nerve,Cells, Nerve,Nerve Cell,Neuron
D010300 Parkinson Disease A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75) Idiopathic Parkinson Disease,Lewy Body Parkinson Disease,Paralysis Agitans,Primary Parkinsonism,Idiopathic Parkinson's Disease,Lewy Body Parkinson's Disease,Parkinson Disease, Idiopathic,Parkinson's Disease,Parkinson's Disease, Idiopathic,Parkinson's Disease, Lewy Body,Parkinsonism, Primary
D004298 Dopamine One of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action. Hydroxytyramine,3,4-Dihydroxyphenethylamine,4-(2-Aminoethyl)-1,2-benzenediol,Dopamine Hydrochloride,Intropin,3,4 Dihydroxyphenethylamine,Hydrochloride, Dopamine
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000418 Albumins Water-soluble proteins found in egg whites, blood, lymph, and other tissues and fluids. They coagulate upon heating. Albumin

Related Publications

C H Konings, and M A Kuiper, and P L Bergmans, and A M Grijpma, and G J van Kamp, and E C Wolters
March 1992, Clinical chemistry,
C H Konings, and M A Kuiper, and P L Bergmans, and A M Grijpma, and G J van Kamp, and E C Wolters
March 1985, Brain research,
C H Konings, and M A Kuiper, and P L Bergmans, and A M Grijpma, and G J van Kamp, and E C Wolters
January 1988, Brain research,
C H Konings, and M A Kuiper, and P L Bergmans, and A M Grijpma, and G J van Kamp, and E C Wolters
October 1987, Klinische Wochenschrift,
C H Konings, and M A Kuiper, and P L Bergmans, and A M Grijpma, and G J van Kamp, and E C Wolters
March 1993, Schizophrenia research,
C H Konings, and M A Kuiper, and P L Bergmans, and A M Grijpma, and G J van Kamp, and E C Wolters
May 1984, Biological psychiatry,
C H Konings, and M A Kuiper, and P L Bergmans, and A M Grijpma, and G J van Kamp, and E C Wolters
May 1997, Progress in neuro-psychopharmacology & biological psychiatry,
C H Konings, and M A Kuiper, and P L Bergmans, and A M Grijpma, and G J van Kamp, and E C Wolters
January 1998, Schizophrenia bulletin,
C H Konings, and M A Kuiper, and P L Bergmans, and A M Grijpma, and G J van Kamp, and E C Wolters
April 1987, Journal of hypertension,
C H Konings, and M A Kuiper, and P L Bergmans, and A M Grijpma, and G J van Kamp, and E C Wolters
January 2005, Annales de biologie clinique,
Copied contents to your clipboard!